MYC and posterior cortical atrophy: In a recent study, the authors found that KMT2C mutations were associated with PCa metastasis, and in addition, they found that KMT2C mutations were associated with reduced PCa disease-free survival, and that inhibition of the MYC signaling axis may be a viable therapeutic option for patients with KMT2C truncation (121).